Glucagon-like peptide-1 receptor agonists are leaders in reducing cardiovascular risk in patients with type 2 diabetes mellitus

Yu. M. Gromova; A. A. Bova; Ю. М. Громова; А. А. Бова

For citations:

Gromova Yu.M., Bova A.A. Glucagon-like peptide-1 receptor agonists are leaders in reducing cardiovascular risk in patients with type 2 diabetes mellitus. Military Medicine. 2021;(4):101-105. (In Russ.) https://doi.org/10.51922/2074-5044.2021.4.101

Views PDF (Rus): 8

JATS XML

This work is licensed under a Creative Commons Attribution 4.0 License.

ISSN 2074-5044 (Print)

Username
Password
	Remember me
Not a user? Register with this site Forgot your password?

User

Military Medicine

For citations:

Cookies policy